Background: Influenza vaccines are updated every year to match the vaccine strains with currently circulating viruses; consequently influenza vaccine effectiveness (IVE) has to be assessed annually.Research design and methods: A test-negative case-control study was conducted within the context of the Italian sentinel influenza surveillance network to estimate IVE by age group, virus subtype, and vaccine brand in medically attended laboratory-confirmed influenza. Results: In Italy, the 2018/19 influenza season was characterized by the co-circulation of influenza A(H1N1)pdm09 and A(H3N2) viruses. The adjusted IVE estimate in preventing influenza was moderate (44.8%, 95% CI: 18.8 to 62.5) against A(H1N1)pdm09, whereas there was no evidence of effectiveness (1.8%, 95% CI: -37.8 to 30.1) in persons affected by A(H3N2). IVE against A(H1N1)pdm09 decreased with age ranging from 65.7% to 13.1% among children/adolescents and elderly, respectively; moreover results suggest that Vaxigrip Tetra® was more effective against A(H1N1)pdm09 compared to Fluarix Tetra® [62.5% (95% CI: 34.3 to 78.6) vs 24.5% (95% CI: -40.6 to 59.6)]. Low effectiveness (35.2%, 95% CI: -50.8 to 72.1) against A(H3N2) was detected only in the elderly immunized with Fluad®.Conclusions: Findings suggest that influenza vaccines were low to moderately effective, probably due to a mismatch between circulating and vaccine strains.
Background: Influenza vaccines are updated every year to match the vaccine strains with currently circulating viruses; consequently influenza vaccine effectiveness (IVE) has to be assessed annually.Research design and methods: A test-negative case-control study was conducted within the context of the Italian sentinel influenza surveillance network to estimate IVE by age group, virus subtype, and vaccine brand in medically attended laboratory-confirmed influenza. Results: In Italy, the 2018/19 influenza season was characterized by the co-circulation of influenza A(H1N1)pdm09 and A(H3N2) viruses. The adjusted IVE estimate in preventing influenza was moderate (44.8%, 95% CI: 18.8 to 62.5) against A(H1N1)pdm09, whereas there was no evidence of effectiveness (1.8%, 95% CI: -37.8 to 30.1) in persons affected by A(H3N2). IVE against A(H1N1)pdm09 decreased with age ranging from 65.7% to 13.1% among children/adolescents and elderly, respectively; moreover results suggest that Vaxigrip Tetra® was more effective against A(H1N1)pdm09 compared to Fluarix Tetra® [62.5% (95% CI: 34.3 to 78.6) vs 24.5% (95% CI: -40.6 to 59.6)]. Low effectiveness (35.2%, 95% CI: -50.8 to 72.1) against A(H3N2) was detected only in the elderly immunized with Fluad®.Conclusions: Findings suggest that influenza vaccines were low to moderately effective, probably due to a mismatch between circulating and vaccine strains.
Entities:
Keywords:
Influenza vaccine effectiveness; Italy; national influenza surveillance network; test-negative case-control study
Authors: Sara Boccalini; Elena Pariani; Giovanna Elisa Calabrò; Chiara DE Waure; Donatella Panatto; Daniela Amicizia; Piero Luigi Lai; Caterina Rizzo; Emanuele Amodio; Francesco Vitale; Alessandra Casuccio; Maria Luisa DI Pietro; Cristina Galli; Laura Bubba; Laura Pellegrinelli; Leonardo Villani; Floriana D'Ambrosio; Marta Caminiti; Elisa Lorenzini; Paola Fioretti; Rosanna Tindara Micale; Davide Frumento; Elisa Cantova; Flavio Parente; Giacomo Trento; Sara Sottile; Andrea Pugliese; Massimiliano Alberto Biamonte; Duccio Giorgetti; Marco Menicacci; Antonio D'Anna; Claudia Ammoscato; Emanuele LA Gatta; Angela Bechini; Paolo Bonanni Journal: J Prev Med Hyg Date: 2021-09-10
Authors: Ilaria Manini; Andrea Camarri; Serena Marchi; Claudia Maria Trombetta; Ilaria Vicenti; Filippo Dragoni; Giacomo Lazzeri; Giovanni Bova; Emanuele Montomoli; Pier Leopoldo Capecchi Journal: Int J Environ Res Public Health Date: 2021-04-07 Impact factor: 3.390
Authors: Anca Cristina Drăgănescu; Victor Daniel Miron; Anca Streinu-Cercel; Dragoş Florea; Ovidiu Vlaicu; Anuţa Bilaşco; Dan Oţelea; Monica Luminiţa Luminos; Daniela Piţigoi; Adrian Streinu-Cercel; Oana Săndulescu Journal: Medicine (Baltimore) Date: 2021-12-30 Impact factor: 1.889
Authors: Giovanna Elisa Calabrò; Sara Boccalini; Donatella Panatto; Caterina Rizzo; Maria Luisa Di Pietro; Fasika Molla Abreha; Marco Ajelli; Daniela Amicizia; Angela Bechini; Irene Giacchetta; Piero Luigi Lai; Stefano Merler; Chiara Primieri; Filippo Trentini; Sara Violi; Paolo Bonanni; Chiara de Waure Journal: Int J Environ Res Public Health Date: 2022-03-31 Impact factor: 3.390
Authors: Andri Frediansyah; Fajar Sofyantoro; Saad Alhumaid; Abbas Al Mutair; Hawra Albayat; Hayyan I Altaweil; Hani M Al-Afghani; Abdullah A AlRamadhan; Mariam R AlGhazal; Safaa A Turkistani; Abdulmonem A Abuzaid; Ali A Rabaan Journal: Molecules Date: 2022-07-05 Impact factor: 4.927